510(k) K180175
K180175 is an FDA 510(k) premarket notification submitted by View Point Medical, Inc. for the device "SignalMark Lung Biopsy Site Marker". The FDA issued a decision of Substantially Equivalent on December 7, 2018. The device falls under product code GDW (Staple, Implantable), a Class II device regulated under 21 CFR 878.4750. View Point Medical, Inc. has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 7, 2018
- Date Received
- January 22, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Staple, Implantable
- Device Class
- Class II
- Regulation Number
- 878.4750
- Review Panel
- SU
- Submission Type